Evidence map›Paper›PMID 33224942›Full record

ArticleFrontiers in physics2020

Biomedical Research Programs at Present and Future High-Energy Particle Accelerators.

Vincenzo Patera, Yolanda Prezado, Faical Azaiez, Giuseppe Battistoni, Diego Bettoni, Sytze Brandenburg, Aleksandr Bugay, Giacomo Cuttone, Denis Dauvergne, Gilles de France and 10 more

Abstract read
In one paragraph

Article in Frontiers in physics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Vincenzo PateraDipartimento di Scienze di Base e Applicate per l'Ingegneria, University "La Sapienza", Rome, Italy.
Yolanda PrezadoInstitut Curie, University Paris Saclay, Orsay, France.
Faical AzaieziThemba LABS, NRF, Cape Town, South Africa.
Giuseppe BattistoniTIFPA, INFN, Trento, Italy.
Diego BettoniLNL, INFN, Legnaro, Italy.
Sytze BrandenburgKVI-CART, University of Groningen, Groningen, Netherlands.
Aleksandr BugayJINR, Dubna, Russia.
Giacomo CuttoneLNS, INFN, Catania, Italy.
Denis DauvergneUniversité Grenoble-Alpes, CNRS/IN2P3, UMR5821, LPSC, GDR MI2B, LabEx PRIMES, Grenoble, France.
Gilles de FranceGANIL, Caen, France.
Christian GraeffBiophysics Department, GSI Helmholtzzentrum für Schwerionenforschung, Darmstadt, Germany.
Thomas HabererHIT, University of Heidelberg, Heidelberg, Germany.
Taku InaniwaNIRS, QST, Chiba, Japan.
Sebastien IncertiUniversité de Bordeaux, CNRS/IN2P3, UMR5797, Centre d'Études Nucléaires de Bordeaux Gradignan, Gradignan, France.
Elena NasonovaJINR, Dubna, Russia.
Alahari NavinGANIL, Caen, France.
Marco PulliaCNAO, Pavia, Italy.
Sandro RossiCNAO, Pavia, Italy.
Charlot VandevoordeiThemba LABS, NRF, Cape Town, South Africa.
Marco DuranteBiophysics Department, GSI Helmholtzzentrum für Schwerionenforschung, Darmstadt, Germany.

Funding

European Research Council 883425
6 · The paper itself

Abstract

Biomedical applications at high-energy particle accelerators have always been an important section of the applied nuclear physics research. Several new facilities are now under constructions or undergoing major upgrades. While the main goal of these facilities is often basic research in nuclear physics, they acknowledge the importance of including biomedical research programs and of interacting with other medical accelerator facilities providing patient treatments. To harmonize the programs, avoid duplications, and foster collaboration and synergism, the International Biophysics Collaboration is providing a platform to several accelerator centers with interest in biomedical research. In this paper, we summarize the programs of various facilities in the running, upgrade, or construction phase.

Indexed as

acceleratorsbiomedical researchhigh-energy ionsparticle therapyspace radiation protection

Identifiers

PMID33224942
PMCPMC7116397

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.